Endocrinology, Vol 136, 5461-5468, Copyright © 1995 by Endocrine Society

ARTICLES

Apoptosis contributes to the involution of beta cell mass in the post partum rat pancreas

L Scaglia, FE Smith and S Bonner-Weir
E. P. Joslin Research Laboratories, Joslin Diabetes Center, Boston, Massachusetts 02215, USA.

A significant reduction of beta cell mass has been described during the post partum period in the endocrine rat pancreas. We examined the mechanisms of this involution in Sprague Dawley rats by analyzing beta cell mass, beta cell replication, and beta cell size at end of pregnancy and 4 and 10 days after delivery. beta cell replication was significantly decreased at 4 days post partum but had returned back to nonpregnant levels by 10 days post partum. Similarly, beta cell size was significantly decreased at 4 and 10 days post partum as compared with the end of pregnancy, and at 10 days post partum was significantly decreased as compared with controls. At 4-6 days post partum, DNA fragmentation characteristic of apoptosis (programmed cell death) was detected in pancreatic islets, as assessed by in situ terminal deoxynucleotidyl transferase and nick translation assay. Only occasional cells were labeled with this assay in nonpregnant rats and at other time points after delivery. Condensed chromatin and apoptotic bodies, the morphological characteristics of apoptosis, were detected in beta cells of pancreatic islet at 3 and 4 days after delivery by electron microscopic analysis, confirming the occurrence of apoptosis in involuting islets. The expression of TRPM 2 and TGF beta 1, often enhanced in models of apoptosis, were studied during the post partum period by Northern blot analysis and immunohistochemistry. Levels of TRPM 2 gene and its protein, clusterin, were not different from controls; however, the TGF beta 1 gene and its protein expression were enhanced at 3 days post partum. Our study confirms the capability of beta cells to down-regulate their mass using the mechanisms of changes in rates of beta cell replication and of beta cell death, and changes in beta cell size to achieve homeostasis of the functional endocrine tissue.

This article has been cited by other articles:

				T. L. Jetton, B. Everill, J. Lausier, V. Roskens, A. Habibovic, K. LaRock, A. Gokin, M. Peshavaria, and J. L. Leahy Enhanced {beta}-cell mass without increased proliferation following chronic mild glucose infusion Am J Physiol Endocrinol Metab, April 1, 2008; 294(4): E679 - E687. [Abstract] [Full Text] [PDF]

				T. Brun and B. R Gauthier A focus on the role of Pax4 in mature pancreatic islet {beta}-cell expansion and survival in health and disease J. Mol. Endocrinol., February 1, 2008; 40(2): 37 - 45. [Abstract] [Full Text] [PDF]

				S. K. Karnik, H. Chen, G. W. McLean, J. J. Heit, X. Gu, A. Y. Zhang, M. Fontaine, M. H. Yen, and S. K. Kim Menin Controls Growth of Pancreatic {beta}-Cells in Pregnant Mice and Promotes Gestational Diabetes Mellitus Science, November 2, 2007; 318(5851): 806 - 809. [Abstract] [Full Text] [PDF]

				S. Hanley and L. Rosenberg Transforming Growth Factor {beta} Is a Critical Regulator of Adult Human Islet Plasticity Mol. Endocrinol., June 1, 2007; 21(6): 1467 - 1477. [Abstract] [Full Text] [PDF]

				A. M Ackermann and M. Gannon Molecular regulation of pancreatic {beta}-cell mass development, maintenance, and expansion J. Mol. Endocrinol., February 1, 2007; 38(2): 193 - 206. [Abstract] [Full Text] [PDF]

				D. M. Simeone, L. Zhang, M. K. Treutelaar, L. Zhang, K. Graziano, C. D. Logsdon, and C. F. Burant Islet hypertrophy following pancreatic disruption of Smad4 signaling Am J Physiol Endocrinol Metab, December 1, 2006; 291(6): E1305 - E1316. [Abstract] [Full Text] [PDF]

				D. Liuwantara, M. Elliot, M. W. Smith, A. O. Yam, S. N. Walters, E. Marino, A. McShea, and S. T. Grey Nuclear Factor-{kappa}B Regulates {beta}-Cell Death: A Critical Role for A20 in {beta}-Cell Protection Diabetes, September 1, 2006; 55(9): 2491 - 2501. [Abstract] [Full Text] [PDF]

				H. Zhang, A. M. Ackermann, G. A. Gusarova, D. Lowe, X. Feng, U. G. Kopsombut, R. H. Costa, and M. Gannon The FoxM1 Transcription Factor Is Required to Maintain Pancreatic {beta}-Cell Mass Mol. Endocrinol., August 1, 2006; 20(8): 1853 - 1866. [Abstract] [Full Text] [PDF]

				L. Bouwens and I. Rooman Regulation of Pancreatic Beta-Cell Mass Physiol Rev, October 1, 2005; 85(4): 1255 - 1270. [Abstract] [Full Text] [PDF]

				I. C. Mcmillen and J. S. Robinson Developmental Origins of the Metabolic Syndrome: Prediction, Plasticity, and Programming Physiol Rev, April 1, 2005; 85(2): 571 - 633. [Abstract] [Full Text] [PDF]

				M. J. Luther, E. Davies, D. Muller, M. Harrison, A. J. Bone, S. J. Persaud, and P. M. Jones Cell-to-cell contact influences proliferative marker expression and apoptosis in MIN6 cells grown in islet-like structures Am J Physiol Endocrinol Metab, March 1, 2005; 288(3): E502 - E509. [Abstract] [Full Text] [PDF]

				M. E C Amaral, D. A Cunha, G. F Anhe, M. Ueno, E. M Carneiro, L. A Velloso, S. Bordin, and A. C Boschero Participation of prolactin receptors and phosphatidylinositol 3-kinase and MAP kinase pathways in the increase in pancreatic islet mass and sensitivity to glucose during pregnancy J. Endocrinol., December 1, 2004; 183(3): 469 - 476. [Abstract] [Full Text] [PDF]

				L. M. Dickson and C. J. Rhodes Pancreatic {beta}-cell growth and survival in the onset of type 2 diabetes: a role for protein kinase B in the Akt? Am J Physiol Endocrinol Metab, August 1, 2004; 287(2): E192 - E198. [Abstract] [Full Text] [PDF]

				J P H Shield, I K Temple, M Sabin, D Mackay, D O Robinson, P R Betts, D J Carson, H Cave, D Chevenne, and M Polak An assessment of pancreatic endocrine function and insulin sensitivity in patients with transient neonatal diabetes in remission Arch. Dis. Child. Fetal Neonatal Ed., July 1, 2004; 89(4): F341 - F343. [Abstract] [Full Text] [PDF]

				B.-H. Min, B.-M. Kim, S.-H. Lee, S.-W. Kang, M. Bendayan, and I.-S. Park Clusterin Expression in the Early Process of Pancreas Regeneration in the Pancreatectomized Rat J. Histochem. Cytochem., October 1, 2003; 51(10): 1355 - 1365. [Abstract] [Full Text] [PDF]

				A. E. Butler, J. Janson, W. C. Soeller, and P. C. Butler Increased {beta}-Cell Apoptosis Prevents Adaptive Increase in {beta}-Cell Mass in Mouse Model of Type 2 Diabetes: Evidence for Role of Islet Amyloid Formation Rather Than Direct Action of Amyloid Diabetes, September 1, 2003; 52(9): 2304 - 2314. [Abstract] [Full Text] [PDF]

				M. Paris, C. Bernard-Kargar, M.-F. Berthault, L. Bouwens, and A. Ktorza Specific and Combined Effects of Insulin and Glucose on Functional Pancreatic {beta}-Cell Mass in Vivo in Adult Rats Endocrinology, June 1, 2003; 144(6): 2717 - 2727. [Abstract] [Full Text] [PDF]

				K. H. Yoon, S. H. Ko, J. H. Cho, J. M. Lee, Y. B. Ahn, K. H. Song, S. J. Yoo, M. I. Kang, B. Y. Cha, K. W. Lee, et al. Selective {beta}-Cell Loss and {alpha}-Cell Expansion in Patients with Type 2 Diabetes Mellitus in Korea J. Clin. Endocrinol. Metab., May 1, 2003; 88(5): 2300 - 2308. [Abstract] [Full Text] [PDF]

				D. R. Laybutt, M. Glandt, G. Xu, Y. B. Ahn, N. Trivedi, S. Bonner-Weir, and G. C. Weir Critical Reduction in beta -Cell Mass Results in Two Distinct Outcomes over Time. ADAPTATION WITH IMPAIRED GLUCOSE TOLERANCE OR DECOMPENSATED DIABETES J. Biol. Chem., January 24, 2003; 278(5): 2997 - 3005. [Abstract] [Full Text] [PDF]

				S. Srinivasan, E. Bernal-Mizrachi, M. Ohsugi, and M. A. Permutt Glucose promotes pancreatic islet beta -cell survival through a PI 3-kinase/Akt-signaling pathway Am J Physiol Endocrinol Metab, October 1, 2002; 283(4): E784 - E793. [Abstract] [Full Text] [PDF]

				D. R. Laybutt, G. C. Weir, H. Kaneto, J. Lebet, R. D. Palmiter, A. Sharma, and S. Bonner-Weir Overexpression of c-Myc in {beta}-Cells of Transgenic Mice Causes Proliferation and Apoptosis, Downregulation of Insulin Gene Expression, and Diabetes Diabetes, June 1, 2002; 51(6): 1793 - 1804. [Abstract] [Full Text] [PDF]

				D. R. Laybutt, H. Kaneto, W. Hasenkamp, S. Grey, J.-C. Jonas, D. C. Sgroi, A. Groff, C. Ferran, S. Bonner-Weir, A. Sharma, et al. Increased Expression of Antioxidant and Antiapoptotic Genes in Islets That May Contribute to {beta}-Cell Survival During Chronic Hyperglycemia Diabetes, February 1, 2002; 51(2): 413 - 423. [Abstract] [Full Text] [PDF]

				M. Biarnes, M. Montolio, V. Nacher, M. Raurell, J. Soler, and E. Montanya {beta}-Cell Death and Mass in Syngeneically Transplanted Islets Exposed to Short- and Long-Term Hyperglycemia Diabetes, January 1, 2002; 51(1): 66 - 72. [Abstract] [Full Text] [PDF]

				I. Berkovich and S. Efrat Inducible and Reversible {beta}-Cell Autoimmunity and Hyperplasia in Transgenic Mice Expressing a Conditional Oncogene Diabetes, October 1, 2001; 50(10): 2260 - 2267. [Abstract] [Full Text]

				M. Federici, M. Hribal, L. Perego, M. Ranalli, Z. Caradonna, C. Perego, L. Usellini, R. Nano, P. Bonini, F. Bertuzzi, et al. High Glucose Causes Apoptosis in Cultured Human Pancreatic Islets of Langerhans: A Potential Role for Regulation of Specific Bcl Family Genes Toward an Apoptotic Cell Death Program Diabetes, June 1, 2001; 50(6): 1290 - 1301. [Abstract] [Full Text]

				A. GAROFANO, P. CZERNICHOW, and B. BRÉANT Impaired {beta}-cell regeneration in perinatally malnourished rats: a study with STZ FASEB J, December 1, 2000; 14(15): 2611 - 2617. [Abstract] [Full Text]

				S. Bonner-Weir Perspective: Postnatal Pancreatic {beta} Cell Growth Endocrinology, June 1, 2000; 141(6): 1926 - 1929. [Full Text] [PDF]

				R. C. Vasavada, A. Garcia-Ocana, W. S. Zawalich, R. L. Sorenson, P. Dann, M. Syed, L. Ogren, F. Talamantes, and A. F. Stewart Targeted Expression of Placental Lactogen in the Beta Cells of Transgenic Mice Results in Beta Cell Proliferation, Islet Mass Augmentation, and Hypoglycemia J. Biol. Chem., May 12, 2000; 275(20): 15399 - 15406. [Abstract] [Full Text] [PDF]

				Y.-P. Zhou, J. C. Pena, M. W. Roe, A. Mittal, M. Levisetti, A. C. Baldwin, W. Pugh, D. Ostrega, N. Ahmed, V. P. Bindokas, et al. Overexpression of Bcl-xL in beta -cells prevents cell death but impairs mitochondrial signal for insulin secretion Am J Physiol Endocrinol Metab, February 1, 2000; 278(2): E340 - E351. [Abstract] [Full Text] [PDF]

				A. Garcia-Ocana, K. K. Takane, M. A. Syed, W. M. Philbrick, R. C. Vasavada, and A. F. Stewart Hepatocyte Growth Factor Overexpression in the Islet of Transgenic Mice Increases Beta Cell Proliferation, Enhances Islet Mass, and Induces Mild Hypoglycemia J. Biol. Chem., January 14, 2000; 275(2): 1226 - 1232. [Abstract] [Full Text] [PDF]

				B. Blondeau, A. Garofano, P. Czernichow, and B. Bréant Age-Dependent Inability of the Endocrine Pancreas to Adapt to Pregnancy: A Long-Term Consequence of Perinatal Malnutrition in the Rat Endocrinology, September 1, 1999; 140(9): 4208 - 4213. [Abstract] [Full Text]

				C. BERNARD, M.-F. BERTHAULT, C. SAULNIER, and A. KTORZA Neogenesis vs. apoptosis as main components of pancreatic ß cell mass changes in glucose-infused normal and mildly diabetic adult rats FASEB J, July 1, 1999; 13(10): 1195 - 1205. [Abstract] [Full Text]

				S. E. Porter, R. L. Sorenson, P. Dann, A. Garcia-Ocana, A. F. Stewart, and R. C. Vasavada Progressive Pancreatic Islet Hyperplasia in the Islet-Targeted, Parathyroid Hormone-Related Protein-Overexpressing Mouse Endocrinology, September 1, 1998; 139(9): 3743 - 3751. [Abstract] [Full Text] [PDF]

				J. Petrik, E. Arany, T. J. McDonald, and D. J. Hill Apoptosis in the Pancreatic Islet Cells of the Neonatal Rat Is Associated with a Reduced Expression of Insulin-Like Growth Factor II that May Act as a Survival Factor Endocrinology, June 1, 1998; 139(6): 2994 - 3004. [Abstract] [Full Text] [PDF]

				L. Scaglia, C. J. Cahill, D. T. Finegood, and S. Bonner-Weir Apoptosis Participates in the Remodeling of the Endocrine Pancreas in the Neonatal Rat Endocrinology, April 1, 1997; 138(4): 1736 - 1741. [Abstract] [Full Text] [PDF]